What is the normal level of Carcinoembryonic Antigen (CEA) in adults, particularly for those with a history of colon cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal CEA Level in Adults

The normal CEA level is less than 5 ng/mL, though some evidence suggests that levels above 2.35 ng/mL may indicate worse prognosis in colon cancer patients. 1

Standard Reference Range

  • The widely accepted upper limit of normal for CEA is 5 ng/mL in adults, as established by the American Society of Clinical Oncology 2, 3
  • This threshold is used for both diagnostic and prognostic purposes in clinical practice 4

Refined Thresholds for Colon Cancer Patients

For patients with a history of colon cancer, more nuanced interpretation is warranted:

  • Post-operative CEA >5 ng/mL suggests worse outcome and potential recurrence 1
  • CEA >2.35 ng/mL may also indicate poorer prognosis, though the guideline text appears truncated at this value 1
  • Recent research demonstrates that even CEA ≥2.1 ng/mL (within the traditional "normal" range) is an independent risk factor for worse disease-free survival in patients who underwent curative resection 5

Clinical Context Matters

Several non-malignant conditions can elevate CEA, making interpretation critical:

  • Smoking history commonly elevates CEA levels 2, 4
  • Inflammatory bowel disease, gastritis, peptic ulcer disease, and diverticulitis can raise CEA 2, 3, 4
  • Liver diseases, COPD, diabetes, and other inflammatory states affect CEA levels 2, 3
  • Benign biliary obstruction, especially with cholangitis or liver abscess, can significantly elevate CEA 2

Prognostic Significance in Colon Cancer

Preoperative CEA levels carry independent prognostic value:

  • CEA ≥5 ng/mL preoperatively correlates with poorer prognosis regardless of tumor stage 1, 2, 3, 6
  • Elevated preoperative CEA is an independent prognostic variable with a relative risk of recurrence of 3.74 7
  • The prognostic impact is particularly significant in stage II disease 6
  • CEA levels correlate with tumor stage, with highest values in stage IV disease 7

Monitoring Recommendations for Colon Cancer Survivors

For patients with stage II or III colon cancer after curative resection:

  • Measure CEA every 3 months for at least 3 years after diagnosis 2, 3, 8
  • Any elevation above baseline warrants confirmation with repeat testing 2
  • Rising CEA strongly suggests disease progression even without radiographic confirmation 2
  • CEA has 77% sensitivity and 98% specificity for detecting recurrence, with 100% sensitivity for liver metastases 7

Important Caveats

  • CEA is not suitable for cancer screening in asymptomatic populations due to low sensitivity despite high specificity 2, 3
  • CEA alone should never be used to diagnose cancer or initiate treatment without histologic confirmation 2
  • During the first 4-6 weeks of chemotherapy, CEA may be transiently elevated and should be interpreted cautiously 2, 3
  • Markedly elevated CEA (>25 ng/mL) is highly suggestive of metastatic disease, particularly hepatic metastases 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of a Positive Carcinoembryonic Antigen (CEA) Test Result

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CEA Levels in Colorectal Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Sigmoid Mass with Elevated CEA

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.